NCT02201342View on ClinicalTrials.gov

Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Single Ventricle Heart Disease After Fontan Surgery
Interventions
DRUG

Udenafil

Drug

Trial Locations (6)

19104

Children's Hospital of Philadelphia, Philadelphia

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46201

Riley Hospital for Children, Indianapolis

84113

Primary Children's Medical Center, Salt Lake City

48109-4204

University of Michigan Congenital Heart Center, Ann Arbor

M5G1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Pediatric Heart Network

OTHER

lead

Mezzion Pharma Co. Ltd

INDUSTRY

NCT02201342 - Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents | Biotech Hunter | Biotech Hunter